The pharmaceutical company said late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in the risk of the disease progressing or death.

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer ...

Amgen's Imdelltra reduced the risk of death by 40% compared to chemotherapy for small cell lung cancer patients whose disease ...

Two Scottish health boards are trialing a revolutionary artificial intelligence scanning of X-rays to detect signs of lung ...

Smoking affects many parts of the body, especially the lungs and heart. Regular health checkups can help catch problems early ...

qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA ... patients with previous or current evidence of interstitial lung disease (ILD) were excluded. An Eastern ...

In parallel, we compared CH frequency in published data from 5,003 patients with solid tumor (2,279 lung cancer) who had pretreatment blood sequencing performed through Memorial Sloan ...

Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced the official launch ...

New robotic technology has arrived at Puyallup’s MultiCare Good Samaritan Hospital – and it creates a world of difference for lung cancer patients in Pierce County. The DaVinci ION robotic surgery ...